As proof of concept, we investigated the frequency of CD73-expressing CD8+ T cells in the cerebrospinal fluids (CSF) of relapsing-remitting multiple sclerosis (MS) patients at the time of disease remission versus relapse. Here, CD8A is linked to myeloid sarcoma.